HEALTHCARE GLOBAL ENTERPRISES LIMITED HealthCare Global Enterprises Limited Bombay S.E.
Equities
HCG
INE075I01017
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 358.4 INR | -1.39% |
|
-3.33% | -2.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company is a provider of specialty healthcare focused on cancer and fertility. Under the HCG brand, the Company operates cancer care network in India in terms of the total number of private cancer treatment centers. The Company also provide fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology focused approach to diagnosis and treatment. Under the Triesta brand, it offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company also operates comprehensive cancer care center in Indore, Madhya Pradesh. The Company is also engaged in radiation business in Indore, Madhya Pradesh.
Calendar
2024-05-22
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
357.3
INR
Average target price
414.1
INR
Spread / Average Target
+15.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.73% | 85.42B | |
| +16.05% | 84.38B | |
| +10.92% | 29.39B | |
| -12.73% | 17.49B | |
| -3.17% | 16.44B | |
| -1.78% | 15.28B | |
| -0.45% | 12.22B | |
| -31.23% | 11.98B | |
| -2.51% | 11.71B |
- Stock Market
- Equities
- HCG Stock
- HCG Stock
- News HealthCare Global Enterprises Limited
- HealthCare Global Enterprises Swings to Profit in Fiscal Q2
